Federal Register / Vol. 62, No. 195 / Wednesday, October 8, 1997 / Notices 52569

Technology Licensing Specialist, Office

of Technology Transfer, National

Institutes of Health, 6011 Executive

Boulevard, Suite 325, Rockville,

Maryland 20852–3804; telephone: 301/

496–7735 ext. 287; fax: 301/402–0220;

e-mail: CL21R@NIH.GOV.

Information about the patent

applications and pertinent information

not yet publicly described can be

obtained under a Confidential

Disclosure Agreement. Respondees

interested in licensing the invention(s)

will be required to submit an

Application for License to Public Health

Service Inventions.

SUPPLEMENTARY INFORMATION: As part of

its continuing steroid synthesis program

and its expanded mission, the

Contraception and Reproductive Health

Branch, Center for Population, National

Institute of Child Health and Human

Development, has developed several 21-

substituted derivatives of progesterone

for therapeutic applications as

antiprogestational agents.

Preclinical evaluation of these

steroids indicates greater

antiprogestational activity and reduced

antiglucocorticoid activity compared

with mifepristone. These data and those

derived from a number of

endocrinological, reproductive and

receptor binding studies are available

for the process of due diligence. None

of these data has been published.

Radioimmunoassays for these steroids

are being developed. No toxicological

studies have been undertaken, but

extensive safety studies have been

performed on a similar

antiprogestational agent.

Antiprogestational agents have a

broad spectrum of potential therapeutic

uses in gynecic medicine including

cervical ripening, endometriosis, uterine

fibroids, breast and endometrial cancer

and postmenopausal hormone

replacement therapy.

Applicants for licensing are

encouraged to submit a research plan

which encompasses the most extensive

development for therapeutic use.

Dated: September 26, 1997.

Barbara M. McGarey,

Deputy Director, Office of Technology

Transfer.

[FR Doc. 97–26630 Filed 10–7–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Arthritis and

Musculoskeletal and Skin Diseases;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Arthritis and

Musculoskeletal and Skin Diseases

Special Emphasis Panel (SEP) meeting:

Name of SEP: NIAMS SEP Program Project

Review.

Date: November 19, 1997.

Time: 8:00 a.m.–5:00 p.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Bethesda, Maryland

20815.

Contact Person: Aftab A. Ansari, Ph.D.,

Scientific Review Administrator, Natcher

Building, 45 Center Drive, Rm 5AS25U,

Bethesda, Maryland 20892–6500, Telephone:

301–594–4952.

Purpose/Agenda: To evaluate and review

research grant applications.

This meeting will be closed in accordance

with the provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C. The

discussion of these applications could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the applications, the

disclosure of which would constitute a

clearly unwarranted invasion of personal

privacy.

(Catalog of Federal Domestic Assistance

Program Nos. [93.846, Project Grants in

Arthritis, Musculoskeletal and Skin Diseases

Research], National Institutes of Health,

HHS)

Dated: October 1, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–26627 Filed 10–7–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meetings

Prusant to Section 10(d) of the Federal

Advisory Committee Act, as amended (5

U.S.C. Appendix 2), notice of hereby

given of the following National Institute

of Child Health and Human

Development Initial Review Group

meetings:

Name of Subcommittee: Population

Research Subcommittee.

Date: October 9–10, 1997.

Time: October 9–8:00 a.m.-5:00 p.m.;

October 10–8:00 a.m.-adjournment.

Place: Bethesda Ramada Hotel, 8400

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: A.T. Gregoire, Ph.D.,

Scientific Review Administrator, DSR, 6100

Executive Boulevard, Room 5E01, Bethesda,

Maryland 20892, Telephone: 301–496–1485.

Name of Subcommittee: Population

Research Subcommittee.

Date: October 16, 1997.

Time: 8:00 a.m.-adjournment.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: A.T. Gregoire, Ph.D.,

Scientific Review Administrator, DSR, 6100

Executive Boulevard, Room 5E01, Bethesda,

Maryland 20892, Telephone: 301–496–1485.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the review and funding cycle.

Name of Subcommittee: Mental

Retardation Subcommittee.

Date: October 20, 1997.

Time: 8:00 a.m.-adjournment.

Place: Bethesda Marriott, 5151 Pooks Hill

Road, Bethesda, Maryland 20814.

Contact Person: Norman Chang, Ph.D.,

Scientific Review Administrator, DSR, 6100

Executive Boulevard, Room 5E01, Bethesda,

Maryland 20892, Telephone: 301–496–1485.

Name of Subcommittee: Maternal and

Child Health Research Subcommittee.

Date: October 21–22, 1997.

Time: October 21–8:00 a.m.–5:00 p.m.;

October 22–8:00 a.m.-adjournment.

Place: Holiday Inn-Silver Spring, 8777

Georgia Avenue, Silver Spring, Maryland

20910.

Contact Person: Gopal M. Bhatnagar, Ph.D.,

Scientific Review Administrator, DSR, 6100

Executive Boulevard, Room 5E01, Bethesda,

Maryland 20892, Telephone: 301–496–1485.

Name of Subcommittee: Medical

Rehabilitation Research Subcommittee.

Date: October 22–23, 1997.

Time: October 22–8:30 a.m.–5:00 p.m.;

October 23–8:30 a.m.-adjournment.

Place: Holiday Inn-Chevy Chase, 5520

Wisconsin Avenue, Chevy Chase, Maryland.

Contact Person: Ms. Anne Krey, Scientific

Review Administrator, DSR, 6100 Executive

Boulevard, Room 5E01, Bethesda, Maryland

20892, Telephone: 301–496–1485.

Purpose/Agenda: To evaluate and review

research grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

The discussion of these applications could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications, the disclosure of which would

constitute a clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. [93.864, Population Research

and No. 93.865, Research for Mothers and

Children], National Institutes of Health, HHS)